Bioeconomy Capital is a Washington-based life sciences specialist that leads Seed to Series B rounds, writing checks from $100k to $10 million.
1 person on the investing team, 1 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Bioeconomy Capital reports entry at seed, series a, series b.
Bioeconomy Capital reports checks of $100K to $10M.
Yes. Bioeconomy Capital says it can lead.
Rob Carlson (Managing Director).
No recent activity since September 2026.
Work at Bioeconomy Capital? Claim or correct this profile.